Tumor-specific CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

被引：1
|
作者：
Dragovich, Matthew A.
Davra, Viralkumar
Faber, Matthew S.
Kim, Yoon Kyung
Nisthal, Alex
Zeng, Veronica G.
Jacinto, Jonathan
Diaz, Juan E.
Truong, Thuy
Qi, Jing
Avery, Kendra N.
Rashid, Rumana
Lee, Sung-Hyung
Chu, Seung Y.
Bonzon, Christine
Love, Ruschelle
Bernett, Matthew J.
Ernst, James A.
Bahjat, Rena
Barlow, Norman J.
Desjarlais, John R.
Hedvat, Michael
Moore, Gregory L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2983
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2983
引用
收藏
页数：3
相关论文
共 50 条
  • [31] CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation
    Sepulveda, H
    Cerwenka, A
    Morgan, T
    Dutton, RW
    JOURNAL OF IMMUNOLOGY, 1999, 163 (03): : 1133 - 1142
  • [32] Trifunctional Bispecific Antibodies Induce Tumor-Specific T Cells and Elicit a Vaccination Effect
    Eissler, Nina
    Ruf, Peter
    Mysliwietz, Josef
    Lindhofer, Horst
    Mocikat, Ralph
    CANCER RESEARCH, 2012, 72 (16) : 3958 - 3966
  • [33] Coordinate regulation of T cell activation by CD2 and CD28
    Green, JM
    Karpitskiy, V
    Kimzey, SL
    Shaw, AS
    JOURNAL OF IMMUNOLOGY, 2000, 164 (07): : 3591 - 3595
  • [34] TCR Gene therapy: Single chain TCR coupled to human CD3ε and CD28 shows improved tumor-specific T cell function
    Sebestyen, Zsolt
    Broertjes, Marieke
    Willemsen, Ralph
    Debets, Reno
    HUMAN GENE THERAPY, 2008, 19 (10) : 1084 - 1084
  • [35] T cell retargeting with MHC class I-restricted antibodies: The CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production
    Willemsen, RA
    Ronteltap, C
    Chames, P
    Debets, R
    Bolhuis, RLH
    JOURNAL OF IMMUNOLOGY, 2005, 174 (12): : 7853 - 7858
  • [36] Conditionally active CD28xVISTA bispecific antibodies induce myeloid-driven tumor-specific T-cell co-stimulation for improved cancer immunotherapy
    Thisted, Thomas
    Jiang, Zhi-Gang
    Biesova, Zuzana
    Onumajuru, Adejumoke
    Kleschenko, Yuliya
    Malhotra, Kanam
    Saxena, Vikas
    Mukherjee, Arnab
    Smith, F. Donelson
    van der Horst, Edward H.
    CANCER RESEARCH, 2024, 84 (06)
  • [37] Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28
    Mirenda, Vincenzo
    Jarmin, Sarah J.
    David, Rachel
    Dyson, Julian
    Scott, Diane
    Gu, Yan
    Lechler, Robert I.
    Okkenhaug, Klaus
    Marelli-Berg, Federica M.
    BLOOD, 2007, 109 (07) : 2968 - 2977
  • [38] Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway
    Fenwick, Craig
    Loredo-Varela, Juan-Luis
    Joo, Victor
    Pellaton, Celine
    Farina, Alex
    Rajah, Navina
    Esteves-Leuenberger, Line
    Decaillon, Thibaut
    Suffiotti, Madeleine
    Noto, Alessandra
    Ohmiti, Khalid
    Gottardo, Raphael
    Weissenhorn, Winfried
    Pantaleo, Giuseppe
    JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (07): : 1525 - 1541
  • [39] Cutting edge:: Monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses
    Dennehy, Kevin M.
    Elias, Fernando
    Zeder-Lutz, Gabrielle
    Ding, Xin
    Altschuh, Daniele
    Luehder, Fred
    Huenig, Thomas
    JOURNAL OF IMMUNOLOGY, 2006, 176 (10): : 5725 - 5729
  • [40] Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation (vol 99, pg 11796, 2002)
    Diehn, M
    Alizadeh, AA
    Rando, OJ
    Liu, CL
    Stankunas, K
    Botstein, D
    Crabtree, GR
    Brown, PO
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (23) : 15245 - 15245
12345